1. Increase of Incidence and Mortality of Ovarian Cancer during 2003–2012 in Jiangsu Province, China
   Zhimei Teng et al, 2016, Frontiers in Public Health CrossRef
2. Korean Medical Treatment of Sequela Following Abdominal Surgery with Hyperthermic Intraperitoneal Chemotherapy for Ovarian Cancer: a Case Report
   Su-Yun Cho et al, 2016, The Journal of Oriental Obstetrics and Gynecology CrossRef
3. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy vs. cytoreductive surgery alone for intrahepatic cholangiocarcinoma with peritoneal metastases: A retrospective cohort study
   Feiling Feng et al, 2021, European Journal of Surgical Oncology CrossRef
4. A novel method of bedside hyperthermic intraperitoneal chemotherapy as adjuvant therapy for stage-III gastric cancer
   Lili Liu et al, 2022, International Journal of Hyperthermia CrossRef
5. Nanotechnology-integrated ovarian cancer metastasis therapy: Insights from the metastatic mechanisms into administration routes and therapy strategies
   Yu Huang et al, 2023, International Journal of Pharmaceutics CrossRef
6. Efficacy and safety of intraperitoneal bevacizumab combined with hyperthermic intraperitoneal chemotherapy in the treatment of patients with ovarian cancer and peritoneal effusion and the effect on serum lncRNA H19 and VEGF levels
   Meiling Zhang et al, 2023, Journal of Obstetrics and Gynaecology CrossRef
7. Optimism and the continued promise of maintenance chemotherapy
   John P. Micha et al, 2017, Cancer Chemotherapy and Pharmacology CrossRef
8. Radiofrequency deep hyperthermia combined with chemotherapy in the treatment of advanced non-small cell lung cancer
   Wen-Hui Yang et al, 2019, Chinese Medical Journal CrossRef
9. Progress in the drug encapsulation of poly(lactic-co-glycolic acid) and folate-decorated poly(ethylene glycol)–poly(lactic-co-glycolic acid) conjugates for selective cancer treatment
   Jagan Mohan Dodda et al, 2022, Journal of Materials Chemistry B CrossRef
10. Hyperthermic intraperitoneal chemotherapy (HIPEC) for the management of primary advanced and recurrent ovarian cancer: a systematic review and meta-analysis of randomized trials
    P. Filis et al, 2022, ESMO Open CrossRef